JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2024-11-19 ms4000001835740066 来自广东省

偏重的研究方向：肿瘤
经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2023-05-23 胸外科小大夫来自辽宁省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：外科;综述
经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。

107 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2020-06-12 ms5502585941462392

9月28投稿，10月7日直接接收，还以为是拒稿。😀

585 130

展开130条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2023-05-13 wwei0125 来自山东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志

155 29

展开29条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2024-04-30 huahaha 来自广西

捉急的等待，不知道啥时候有结果。。。
Version 1 (private)
received 11 Mar, 2024

Reviews received
Received 24 Apr, 2024
Reviewers agreed
On 27 Mar, 2024
Reviewers invited
Invitations sent on 21 Mar, 2024
Submission checks complete
On 13 Mar, 2024
Editor assigned
On 13 Mar, 2024
First submitted to Journal of Cancer Research and Clinical Oncology
On 11 Mar, 2024

97 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2024-03-12 ms6000001537745536 来自四川省

二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed

106 31

展开31条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2023-09-13 ms8000001459205604 来自广西

一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？

59 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2024-05-23 1222c49dm85(暂无昵称) 来自新加坡

偏重的研究方向：肿瘤;生信
经验分享：还是很快的，希望期刊越来越好
Publishing and rights
Submission status Date
Publishing and rights complete
07 May 2024
Submission is in publishing and rights
15 Apr 2024
Peer review
Submission status Date
Submission accepted
03 Apr 2024
Submission under peer review
28 Mar 2024
Submission passed technical check
28 Mar 2024
Revision received
27 Mar 2024
Submission under peer review
19 Feb 2024
Technical check
Submission status Date
Submission passed technical check
19 Feb 2024
Submission is under technical check
18 Feb 2024
Submission received
Submission status Date
Submission received
18 Feb 2024

85 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2024-05-23 1222c49dm85(暂无昵称) 来自新加坡

偏重的研究方向：肿瘤;生信
经验分享：过程还是非常快的，希望期刊后面越来越好
Publishing and rights
Submission status Date
Publishing and rights complete
07 May 2024
Submission is in publishing and rights
15 Apr 2024
Peer review
Submission status Date
Submission accepted
03 Apr 2024
Submission under peer review
28 Mar 2024
Submission passed technical check
28 Mar 2024
Revision received
27 Mar 2024
Submission under peer review
19 Feb 2024
Technical check
Submission status Date
Submission passed technical check
19 Feb 2024
Submission is under technical check
18 Feb 2024
Submission received
Submission status Date
Submission received
18 Feb 2024

113 0

[GetPortalCommentsPageByObjectIdResponse(id=2237794, encodeId=f9ca223e794d2, content=偏重的研究方向：肿瘤 经验分享：11-5号投稿，第二天通过技术审核，现在一直停留在“with editor”状态，10天了，正常吗，到底送没送审呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Tue Nov 19 15:11:52 CST 2024, time=2024-11-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;综述 经验分享：4.13投稿，5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿，10月7日直接接收，还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=130, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133642, encodeId=0f3e21336426b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：5.2投稿，5.4技术审查通过；5.4under review；5.9小修，5.11修回，5.12技术审查通过；5.13接收。效率极高的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d09f88778, createdName=wwei0125, createdTime=Sat May 13 21:32:57 CST 2023, time=2023-05-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201278, encodeId=9e2922012e80b, content=捉急的等待，不知道啥时候有结果。。。 Version 1 (private) received 11 Mar, 2024 Reviews received Received 24 Apr, 2024 Reviewers agreed On 27 Mar, 2024 Reviewers invited Invitations sent on 21 Mar, 2024 Submission checks complete On 13 Mar, 2024 Editor assigned On 13 Mar, 2024 First submitted to Journal of Cancer Research and Clinical Oncology On 11 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Tue Apr 30 16:44:27 CST 2024, time=2024-04-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志，去年5月投了篇临床预测模型seer数据库文章，大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157571, encodeId=4451215e57170, content=一审修回，编辑评估后邀请审稿人一周突然又变成编辑审核，啥情况啊铁铁们？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=ms8000001459205604, createdTime=Wed Sep 13 21:01:14 CST 2023, time=2023-09-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2206278, encodeId=6d6422062e8d2, content=偏重的研究方向：肿瘤;生信 经验分享：还是很快的，希望期刊越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:22:25 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2206277, encodeId=c9dc22062e785, content=偏重的研究方向：肿瘤;生信 经验分享：过程还是非常快的，希望期刊后面越来越好 Publishing and rights Submission status Date Publishing and rights complete 07 May 2024 Submission is in publishing and rights 15 Apr 2024 Peer review Submission status Date Submission accepted 03 Apr 2024 Submission under peer review 28 Mar 2024 Submission passed technical check 28 Mar 2024 Revision received 27 Mar 2024 Submission under peer review 19 Feb 2024 Technical check Submission status Date Submission passed technical check 19 Feb 2024 Submission is under technical check 18 Feb 2024 Submission received Submission status Date Submission received 18 Feb 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffa2312172, createdName=1222c49dm85(暂无昵称), createdTime=Thu May 23 19:17:41 CST 2024, time=2024-05-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=24, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省)]

2024-03-26 ms6000000287967542 来自浙江省

求问各位已经proof的大神，接收后一般多久能proof呀？accept是3.11，到现在都没有消息，有些紧张……提前感谢各位大神的解答！

88 24

展开24条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务